In addition, the preliminary results generated in our laboratory, using human PBMC challenged with rND1 alone or in combination with human tumor-derived extracts, suggest, for some tumor types, a synergistic effect on IL-1b expression using the combination, compared to the extract without rND1 (unpublished data). The gene discussed is IL1B; the disease is neoplasm.